Literature DB >> 15695313

Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001.

Helmuth G Doerr1, Markus Bettendorf, Berthold P Hauffa, Otto Mehls, Carl-Joachim Partsch, Elfriede Said, Sabine Sander, Hans-Peter Schwarz, Nikolaus Stahnke, Heiner Steinkamp, Michael B Ranke.   

Abstract

BACKGROUND: To evaluate the factors influencing uterine size in young adult women with Turner syndrome (TS) after long-term growth hormone (GH) treatment.
METHODS: Cross-sectional study. Out of 188 women with TS from 96 German centres, whose longitudinal growth was documented within KIGS (Pfizer International Growth Database), data on uterine size were collected voluntarily at a standardized follow-up visit: 75 TS women (ages: 15.8-30.8 years) with complete data were included. Classification according to karyotype: 45,X (78.6%), 45,X/46,XX (5.4%), 45,X/46,iXq (8%), 45,X/46,XY (8%). Puberty was induced with estrogens in all women. At follow-up, 66 were on cyclic estrogens and progestins.
RESULTS: 13/66 (19.6%) TS women who received estrogens had a reduced uterine length <5 cm. Calculating the data in standard deviation scores (SDS), only women with 45,X/46,XX karyotype had normal median uterine length and volume of 0.6 and 1.59 SDS respectively. An incomplete breast development (Tanner stage B 3) was found in women with 45,X karyotype (n = 11; 18.6%) and with 45,X/46,XY (n = 2).
CONCLUSIONS: Only TS women with karyotype 45,X/46,XX had normal uterine sizes, whereas 26% of the TS women with karyotype 45,X had a uterine length <-2 SDS, and 18% a volume <-2 SDS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695313     DOI: 10.1093/humrep/deh764

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  10 in total

Review 1.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 2.  Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.

Authors:  Laurentiu Craciunas; Nikolaos Zdoukopoulos; Suganthi Vinayagam; Lamiya Mohiyiddeen
Journal:  Cochrane Database Syst Rev       Date:  2022-10-06

3.  Uterine development in Turner syndrome.

Authors:  Vladimir K Bakalov; Thomas Shawker; Irene Ceniceros; Carolyn A Bondy
Journal:  J Pediatr       Date:  2007-09-17       Impact factor: 4.406

Review 4.  The Care of Adolescents and Young Adults with Turner Syndrome: A Pediatric and Adolescent Gynecology Perspective.

Authors:  Tazim Dowlut-McElroy; Roopa Kanakatti Shankar
Journal:  J Pediatr Adolesc Gynecol       Date:  2022-03-08       Impact factor: 2.046

5.  Reproductive and obstetric outcomes in mosaic Turner's Syndrome: a cross-sectional study and review of the literature.

Authors:  Emek Doğer; Yiğit Çakıroğlu; Yasin Ceylan; Esen Ulak; Özkan Özdamar; Eray Çalışkan
Journal:  Reprod Biol Endocrinol       Date:  2015-06-10       Impact factor: 5.211

6.  The predictive role of pelvic magnetic resonance in the follow up of spontaneous or induced puberty in turner syndrome.

Authors:  M C Maggio; A De Pietro; P Porcelli; F Serraino; T Angileri; A Di Peri; G Corsello
Journal:  Ital J Pediatr       Date:  2018-02-13       Impact factor: 2.638

7.  Late-Onset Puberty Induction by Transdermal Estrogen in Turner Syndrome Girls-A Longitudinal Study.

Authors:  Aneta Monika Gawlik; Magdalena Hankus; Kamila Szeliga; Aleksandra Antosz; Tomasz Gawlik; Kamil Soltysik; Agnieszka Drosdzol-Cop; Krzysztof Wilk; Grzegorz Kudela; Tomasz Koszutski; Ewa Malecka-Tendera
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-08       Impact factor: 5.555

8.  Uterine dimensions in gravida 0 phase according to age, body mass index, and height in Chinese infertile women.

Authors:  Hong Gao; Dong-E Liu; Yumei Li; Jing Tang; Shimin Hu; Xinrui Wu; Zhengwen Tian; Hongzhuan Tan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome.

Authors:  Renata C Scalco; Ericka B Trarbach; Edoarda V A Albuquerque; Thais K Homma; Thais H Inoue-Lima; Mirian Y Nishi; Berenice B Mendonca; Alexander A L Jorge
Journal:  Endocr Connect       Date:  2019-11       Impact factor: 3.335

10.  Uterine Development During Induced Puberty in Girls with Turner Syndrome.

Authors:  Monika Obara-Moszynska; Lukasz Dzialach; Barbara Rabska-Pietrzak; Marek Niedziela; Karina Kapczuk
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.